|
Market Closed -
Bombay S.E.
13:02:19 20/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,999.95 INR | -1.12% |
|
+14.52% | +21.41% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 44.28x | 19.44x | 3.67x | - | - | - | 0.97% | 5.38B | |
| 36.57x | 23.32x | 0.7x | 13.2x | 26.79x | 28.38x | 0.54% | 1,141B | |
| 30.41x | - | -1.64x | - | - | - | 1.96% | 659B | |
| 33.95x | -372.55x | 0.15x | 7.85x | 16.34x | 16.96x | 2.58% | 470B | |
| 20.47x | 7.35x | 1.72x | 4.85x | 12.03x | 13.34x | 2.72% | 366B | |
| 22.39x | 6.35x | -13.16x | 5.8x | 14.38x | 15.34x | 2.75% | 302B | |
| 21x | 4.72x | 1.08x | 4.33x | 12.29x | 13x | 2.03% | 254B | |
| 27.98x | 21.14x | 2.52x | 7.21x | 12.8x | 16.54x | 2.28% | 239B | |
| 13.62x | 5.67x | -2.99x | 4.84x | 10.15x | 11.82x | 3.77% | 207B | |
| -45.1x | 10.05x | 0.3x | 6.51x | 25.42x | 62.24x | 2.23% | 183B | |
| 17.7x | 1.83x | 1.02x | 3.35x | 8.55x | 9.75x | 6.1% | 161B | |
| 12.04x | 5.68x | 0.19x | 3.35x | 8.68x | 9.41x | 3.74% | 138B | |
| 32.56x | 6.1x | 3.05x | 9.53x | 21.55x | 22.48x | -.--% | 140B | |
| 12.49x | 1.27x | -7.38x | 2.22x | 7.16x | 7.97x | 5.42% | 110B | |
| 14.48x | 4.66x | -2.32x | 2.83x | 8.37x | 9.32x | 3.63% | 104B | |
| 22.34x | 5.04x | 1.33x | 7.5x | 14.23x | 14.94x | 1.98% | 71.47B | |
| 47.06x | 1.24x | 99.33x | 2.8x | 9.88x | 29.44x | 3.54% | 58.12B | |
| 20.96x | 1.71x | -0.13x | 1.71x | 8.08x | 13.64x | 0.32% | 56.13B | |
| 36.86x | 5.07x | 1.75x | 8.76x | 28.28x | 29.17x | 0.5% | 51.57B | |
| 50.27x | 5.03x | -1.31x | 3.35x | 12.33x | 13.95x | -.--% | 43.66B | |
| Average | 23.62x | -12.47x | 4.39x | 5.55x | 14.30x | 18.76x | 2.35% | 238.02B | |
| Weighted average by Cap. | 25.28x | -31.92x | 0.47x | 7.71x | 17.39x | 20.63x | 2.11% |
- Stock Market
- Stocks
- GLAXO Stock
- Sector GlaxoSmithKline Pharmaceuticals Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
